PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment
Abstract
Authors
D.C. Malone S.L. Charland B.C. Agatep V. Herrera G.S. Hawk B.J. Schrader E.J. Stanek